Profile data is unavailable for this security.
About the company
Kubota Pharmaceutical Holdings Co., Ltd. is a Japan-based company mainly engaged in the operation and management of subsidiaries. Its subsidiaries are mainly engaged in discovering and developing drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases. The Company operates pharmaceutical development segment. It focuses on the development of oral formulation for age-related macular degeneration (AMD), glaucoma and dry eye syndrome.
- Revenue in JPY (TTM)28.27m
- Net income in JPY-768.36m
- Incorporated2015
- Employees19.00
- LocationKubota Pharmaceutical Holdings Co Ltd1-15-37, Minami-AoyamaMINATO-KU 107-0062JapanJPN
- Phone+81 365508928
- Fax+81 365508929
- Websitehttps://www.kubotaholdings.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ReproCell Inc | 2.52bn | -324.61m | 14.03bn | 99.00 | -- | 1.59 | -- | 5.57 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 14.71bn | 58.00 | 40.41 | 8.34 | 54.27 | 14.26 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.40bn | 923.00m | 14.94bn | 214.00 | 16.05 | 1.74 | 12.56 | 2.34 | 18.37 | 18.37 | 127.34 | 169.51 | 0.5080 | 1.77 | 2.62 | -- | 7.34 | -18.99 | 9.32 | -24.04 | 54.42 | 40.20 | 14.44 | -46.31 | 2.72 | -- | 0.0874 | -- | 1.67 | -- | 2.78 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.25bn | 16.50bn | 14.00 | -- | 6.94 | -- | -- | -64.11 | -64.11 | 0.00 | 120.62 | 0.00 | -- | -- | 0.00 | -44.48 | -57.04 | -46.19 | -62.13 | -- | -- | -- | -4,587.85 | -- | -566.18 | -- | -- | -- | -- | 4.27 | -- | -- | -- |
| StemRIM Inc | 0.00 | -1.90bn | 18.24bn | 45.00 | -- | 2.65 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 18.69bn | 648.00 | 7.44 | 0.5452 | 6.60 | 0.052 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 19.97bn | 1.42k | 8.96 | 0.7239 | 4.34 | 0.3183 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.01bn | 22.22bn | 1.34k | -- | 0.5792 | -- | 0.3574 | -469.00 | -469.00 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | 2.32 | 46,394,780.00 | -4.71 | 0.7682 | -9.76 | 1.29 | 26.39 | 26.94 | -6.44 | 1.05 | 0.8228 | 69.88 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Renascience Inc | 86.94m | 34.67m | 22.54bn | 3.00 | 623.72 | 13.79 | 120.88 | 259.23 | 2.73 | 2.73 | 6.84 | 123.38 | 0.0478 | -- | -- | 28,981,330.00 | 1.90 | -8.97 | 2.00 | -9.35 | 95.31 | 84.44 | 39.87 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 28.27m | -768.36m | 25.97bn | 19.00 | -- | 9.14 | -- | 918.66 | -13.41 | -13.41 | 0.4693 | 24.61 | 0.015 | 0.196 | 22.84 | 1,487,632.00 | -40.79 | -41.04 | -44.63 | -44.80 | 74.66 | -- | -2,718.43 | -8,745.21 | 18.25 | -- | 0.0139 | -- | -31.83 | -- | 10.52 | -- | -- | -- |
| RaQualia Pharma Inc | 3.98bn | 273.12m | 27.71bn | 85.00 | 118.77 | 3.78 | 36.39 | 6.96 | 8.97 | 8.97 | 165.54 | 281.96 | 0.3947 | 4.35 | 3.04 | -- | 2.71 | 2.64 | 3.08 | 2.90 | 82.11 | 85.46 | 6.86 | 6.36 | 4.33 | 6.63 | 0.2962 | -- | 28.07 | 29.16 | 155.17 | -- | -13.74 | -- |
| Seikagaku Corp | 35.86bn | -755.00m | 38.58bn | 1.08k | -- | 0.5078 | 28.94 | 1.08 | -13.84 | -13.84 | 656.96 | 1,337.18 | 0.4328 | 2.03 | 3.92 | 33,360,930.00 | -0.9099 | 3.60 | -0.9881 | 3.96 | 40.92 | 52.56 | -2.10 | 7.94 | 4.26 | -- | 0.0049 | 55.17 | 8.73 | 6.57 | -44.46 | -- | 18.48 | 2.90 |
Data as of Feb 16 2026. Currency figures normalised to Kubota Pharmaceutical Holdings Co Ltd's reporting currency: Japanese Yen JPY
2.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Evolution Capital Management LLCas of 05 Jan 2026 | 3.40m | 2.95% |
Data from 04 Feb 2026 - 04 Feb 2026Source: FactSet Research Systems Inc.
